Vaccines Makers Close Lower on Reports RFK Jr May Head HHS
Emergent Biosolutions Insider Sold Shares Worth $272,750, According to a Recent SEC Filing
Emergent BioSolutions (NYSE:EBS) Has Debt But No Earnings; Should You Worry?
India's Business Standard Reported New Study Claims Mpox Clade La Has Evolved To Spread From Human To Human, Citing October 24 Uploaded Paper On Virologica
Emergent Software Welcomes Industry Leader Marc Kermisch as Chief Technology Officer
Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...